Search for: "BRISTOL-MYERS SQUIBB COMPANY"
Results 341 - 360
of 465
Sort by Relevance
|
Sort by Date
8 Mar 2010, 7:49 am
Among the companies that have successfully used the (i)(9) argument to exclude special meeting proposals are: CVS Caremark, Medco, Goldman Sachs, Honeywell, NiSource, Baker Hughes, Becton Dickinson & Co., Eastman Chemical, Safeway, Dow Chemical, Pfizer, Chevron, Bristol-Myers Squibb, and Time Warner. [read post]
22 Feb 2010, 7:42 am
With Bristol-Myers and Windstream, at least 47 U.S. [read post]
16 Feb 2010, 4:31 am
In addition, Time Warner, Genzyme, Bristol-Myers Squibb, International Paper, Pinnacle West Capital, and Liz Claiborne Inc. have filed similar no-action requests to exclude proposals with a 10 percent threshold, according to investors. [read post]
9 Feb 2010, 7:59 am
§1832, from his employer Bristol-Myers-Squibb, where he worked from November 2007 through February 2, 2010. [read post]
7 Feb 2010, 11:28 pm
See Bristol-Myers Squibb Co. v. [read post]
4 Feb 2010, 7:31 am
Jhaveri, a native of India, was a Technical Operations Associate with Bristol-Myers-Squibb for a little over two years until he was fired. [read post]
4 Feb 2010, 7:31 am
Jhaveri, a native of India, was a Technical Operations Associate with Bristol-Myers-Squibb for a little over two years until he was fired." [read post]
3 Feb 2010, 2:00 am
(Docket Report) Sustiva (Efavirenz) – US: Mylan and Matrix fail in bid to dismiss Sustiva case brought by Bristol Myer Squibb (Patent Docs) Temodar (Temozolomide) – US: District Court Delaware: Temador patent unenforceable due to prosecution laches and inequitable conduct: Cancer Research Tech v Barr Labs (Docket Report) (Patent Baristas) (IP Factor) Viread (Tenofovir) – US: Gilead Sciences announces notification of Teva’s ANDA filing for Viread… [read post]
20 Jan 2010, 10:36 am
In addition, Time Warner, Genzyme, Bristol-Myers Squibb, International Paper, Pinnacle West Capital, and Liz Claiborne Inc. have filed similar no-action requests to exclude proposals with a 10 percent threshold, according to investors. [read post]
18 Dec 2009, 9:59 am
12/2: Bristol-Myers Squibb Company, Bristol-Myers Squibb Company, Novartis Corporation, et al. v. [read post]
9 Dec 2009, 3:59 pm
(Patent Docs) (SmartBrief) (GenericsWeb) OxyContin (Oxycodone) – US: Ranbaxy admits infringement in OxyContin suit – District Court S D New York approves consent judgment between Ranbaxy and Purdue Pharma (Patent Docs) Reyataz (Atazanavir) – US: Complaint filed in Delaware: Infringement of US patent following a Paragraph IV challenge: Bristol-Myers Squibb Co. et al. v. [read post]
7 Dec 2009, 2:12 am
Most notably, the parties to the Bristol- Myers Squibb securities class action lawsuit agreed to settle that case for $300 million while the case was on appeal to the Third Circuit following the district court’s dismissal. [read post]
3 Dec 2009, 10:16 pm
Supporters can click the Make it Happen link and send an email to the CEOs of Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer Inc. and Sequoia Pharmaceuticals Inc. [read post]
24 Nov 2009, 1:11 am
Other defendants named in the MDL include Bristol-Myers Squibb Co., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. [read post]
24 Nov 2009, 1:11 am
Other defendants named in the MDL include Bristol-Myers Squibb Co., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. [read post]
9 Nov 2009, 6:01 am
Department of Justice finds that they deceptively marketed drugs for unapproved uses, putting millions of people at risk of chest infections, heart attacks, suicidal impulses or death. $7 Billion in Penalties Since May 2004, Pfizer, Eli Lilly & Co., Bristol-Myers Squibb Co. and four other drug companies have paid a total of $7 billion in fines and penalties. [read post]
2 Nov 2009, 1:24 pm
At the Wall Street Journal, Dow Jones Newswire’s Kristina Peterson addresses the Court’s denial of cert. in a drug-patent dispute between generic drug manufacturer Apotex Corp. and patent-holders Sanofi-Aventis and Bristol-Myers Squibb, while the Associated Press has coverage of the Court’s decision not to hear an appeal to stop the release of documents relating to sexual abuse lawsuits against Roman Catholic priests in… [read post]
28 Oct 2009, 3:54 pm
Bristol-Myers Squibb 7. [read post]
19 Oct 2009, 6:40 am
The conference will feature distinguished speakers from such companies as DuPont, Wal-Mart, American Airlines, Intel, Microsoft, Google, Bristol-Myers Squibb, NBC Universal, GE, Wyeth Pharmaceuticals, Prudential, Freddie Mac, Verizon and many others! [read post]
13 Oct 2009, 9:59 pm
As part of the effort to encourage these companies to pool their patents, MSF has launched an e-mail writing campaign calling on Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline, Merck & Co, Pfizer, and Sequoia Pharmaceuticals to place specific HIV drug patents... [read post]
